Sphera Funds Management as of Sept. 30, 2014
Portfolio Holdings for Sphera Funds Management
Sphera Funds Management holds 128 positions in its portfolio as reported in the September 2014 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Pfizer (PFE) | 7.5 | $38M | 1.3M | 29.57 | |
| Actavis | 5.8 | $30M | 122k | 241.28 | |
| Merck & Co (MRK) | 4.9 | $25M | 418k | 59.28 | |
| Abbvie (ABBV) | 4.6 | $23M | 404k | 57.76 | |
| Allergan Inc Com Stk | 4.6 | $23M | 129k | 178.19 | |
| Shire | 4.5 | $22M | 259k | 86.57 | |
| Johnson & Johnson (JNJ) | 4.4 | $22M | 207k | 106.59 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 3.4 | $17M | 150k | 112.31 | |
| Valeant Pharmaceuticals Int | 2.6 | $13M | 99k | 131.20 | |
| Mallinckrodt Pub | 2.4 | $12M | 136k | 90.15 | |
| United Therapeutics Corporation (UTHR) | 2.3 | $11M | 89k | 128.65 | |
| Teva Pharmaceutical Industries (TEVA) | 2.2 | $11M | 647k | 17.12 | |
| BioMarin Pharmaceutical (BMRN) | 1.8 | $8.8M | 122k | 72.16 | |
| Astrazeneca | 1.7 | $8.6M | 120k | 71.44 | |
| Isram | 1.6 | $8.2M | 103M | 0.08 | |
| Sanofi Aventis Wi Conval Rt | 1.5 | $7.7M | 68k | 113.14 | |
| Puma Biotechnology (PBYI) | 1.4 | $7.2M | 30k | 238.58 | |
| Amgen | 1.4 | $6.8M | 49k | 140.45 | |
| Acorda Therapeutics | 1.3 | $6.7M | 199k | 33.88 | |
| Eli Lilly & Co. (LLY) | 1.2 | $6.3M | 97k | 64.85 | |
| Medivation | 1.2 | $6.2M | 63k | 98.87 | |
| MedAssets | 1.2 | $6.1M | 434k | 14.07 | |
| Seattle Genetics | 1.1 | $5.8M | 155k | 37.18 | |
| Gilead Sciences Inc option | 1.1 | $5.8M | 1.9k | 2968.59 | |
| Dyax | 1.0 | $5.2M | 518k | 10.12 | |
| AMAG Pharmaceuticals | 0.9 | $4.8M | 150k | 31.91 | |
| Clovis Oncology | 0.9 | $4.6M | 102k | 45.36 | |
| Pharmacyclics | 0.9 | $4.6M | 39k | 117.43 | |
| Novartis (NVS) | 0.9 | $4.5M | 479k | 9.41 | |
| GlaxoSmithKline | 0.9 | $4.5M | 97k | 45.97 | |
| Mylan | 0.9 | $4.4M | 97k | 45.49 | |
| Auspex Pharmaceuticals | 0.8 | $4.2M | 165k | 25.67 | |
| Applied Genetic Technol Corp C | 0.8 | $3.9M | 211k | 18.61 | |
| NPS Pharmaceuticals | 0.7 | $3.6M | 139k | 26.00 | |
| Tokai Pharmaceuticals | 0.7 | $3.5M | 230k | 15.14 | |
| Intercept Pharmaceuticals In | 0.7 | $3.4M | 15k | 236.66 | |
| Proqr Thrapeutics N V shs euro (PRQR) | 0.7 | $3.4M | 200k | 17.19 | |
| Aerie Pharmaceuticals | 0.7 | $3.4M | 164k | 20.69 | |
| Cymabay Therapeutics | 0.7 | $3.4M | 490k | 6.84 | |
| Elbit Systems (ESLT) | 0.7 | $3.3M | 145k | 22.84 | |
| Radius Health | 0.6 | $3.2M | 150k | 21.00 | |
| Array BioPharma | 0.6 | $3.1M | 874k | 3.57 | |
| Salix Pharmaceuticals | 0.6 | $3.1M | 20k | 156.25 | |
| Incyte Corporation (INCY) | 0.6 | $3.0M | 61k | 49.06 | |
| Acceleron Pharma | 0.6 | $3.0M | 100k | 30.24 | |
| AVANIR Pharmaceuticals | 0.6 | $3.0M | 250k | 11.92 | |
| Ptc Therapeutics I (PTCT) | 0.6 | $2.8M | 64k | 44.01 | |
| Sage Therapeutics (SAGE) | 0.6 | $2.8M | 88k | 31.50 | |
| Otonomy | 0.5 | $2.7M | 111k | 24.00 | |
| Ironwood Pharmaceuticals (IRWD) | 0.5 | $2.5M | 194k | 12.96 | |
| Vanda Pharmaceuticals (VNDA) | 0.5 | $2.3M | 218k | 10.38 | |
| Catalyst Pharmaceutical Partners (CPRX) | 0.5 | $2.3M | 686k | 3.32 | |
| B Communications (BCOMF) | 0.5 | $2.3M | 321k | 7.08 | |
| Macrogenics (MGNX) | 0.5 | $2.3M | 108k | 20.90 | |
| La Jolla Pharmaceuticl Com Par | 0.4 | $2.1M | 223k | 9.61 | |
| Arena Pharmaceuticals | 0.4 | $2.1M | 500k | 4.19 | |
| Trevena | 0.4 | $2.1M | 331k | 6.42 | |
| Relypsa | 0.4 | $2.0M | 97k | 21.09 | |
| Immunomedics | 0.4 | $2.0M | 534k | 3.72 | |
| Salix Pharmaceuticals Inc option | 0.4 | $2.0M | 485.00 | 4030.93 | |
| Celladon | 0.4 | $1.9M | 186k | 10.46 | |
| Akebia Therapeutics (AKBA) | 0.4 | $2.0M | 90k | 22.13 | |
| Actinium Pharmaceuticals | 0.4 | $2.0M | 291k | 6.70 | |
| Bluebird Bio (BLUE) | 0.4 | $1.9M | 53k | 35.88 | |
| Kite Pharma | 0.4 | $1.9M | 68k | 28.50 | |
| Zafgen | 0.4 | $1.9M | 97k | 19.65 | |
| Alder Biopharmaceuticals | 0.4 | $1.9M | 150k | 12.68 | |
| Marinus Pharmaceuticals | 0.4 | $1.9M | 294k | 6.47 | |
| Prosensa Hldgs B V Shs Usd | 0.4 | $1.8M | 219k | 8.43 | |
| Oncomed Pharmaceuticals | 0.4 | $1.8M | 97k | 18.93 | |
| Ituran Location And Control (ITRN) | 0.4 | $1.8M | 231k | 7.75 | |
| Teva Pharmaceutical Inds Ltd option | 0.4 | $1.8M | 3.8k | 487.64 | |
| Acelrx Pharmaceuticals | 0.3 | $1.6M | 290k | 5.49 | |
| Ignyta | 0.3 | $1.6M | 199k | 8.06 | |
| Spdr S&p Oil & Gas Exp & Pr put | 0.3 | $1.6M | 2.0k | 790.00 | |
| Receptos | 0.3 | $1.6M | 25k | 62.12 | |
| Ocera Therapeutics | 0.3 | $1.6M | 321k | 4.90 | |
| Epizyme | 0.3 | $1.4M | 50k | 27.12 | |
| Cytokinetics (CYTK) | 0.2 | $1.3M | 363k | 3.52 | |
| Genvec | 0.2 | $1.2M | 558k | 2.08 | |
| VALEANT PHARMACEUTICALS Inte call | 0.2 | $1.1M | 972.00 | 1145.06 | |
| Bio Blast Pharma | 0.2 | $1.1M | 150k | 7.27 | |
| Auris Med Hldg | 0.2 | $1.1M | 191k | 5.81 | |
| Palatin Technologies | 0.2 | $1.0M | 1.1M | 0.93 | |
| Mannkind Corp Common Stock cmn | 0.2 | $998k | 3.0k | 332.67 | |
| Israel Chemicals | 0.2 | $994k | 1.4M | 0.72 | |
| Affimed Therapeutics B V | 0.2 | $945k | 150k | 6.30 | |
| Orbotech Ltd Com Stk | 0.2 | $892k | 572k | 1.56 | |
| Discovery Laboratories | 0.2 | $893k | 486k | 1.84 | |
| Verint Systems (VRNT) | 0.2 | $842k | 152k | 5.56 | |
| Oncothyreon | 0.2 | $822k | 428k | 1.92 | |
| Tetrelogic Pharmaceuticals (TLOG) | 0.2 | $808k | 194k | 4.16 | |
| Zs Pharma | 0.2 | $811k | 21k | 39.21 | |
| Nice Systems (NICE) | 0.1 | $664k | 65k | 10.29 | |
| Prothena (PRTA) | 0.1 | $663k | 30k | 22.17 | |
| Select Sector Spdr Tr option | 0.1 | $595k | 4.9k | 122.55 | |
| INSTRS INC Stemcells | 0.1 | $612k | 486k | 1.26 | |
| Kalobios Pharmaceuticals | 0.1 | $542k | 350k | 1.55 | |
| Apple Computer | 0.1 | $504k | 50k | 10.07 | |
| CSX Corporation (CSX) | 0.1 | $448k | 140k | 3.21 | |
| Broadcom Corporation | 0.1 | $402k | 99k | 4.05 | |
| Union Pacific Corporation (UNP) | 0.1 | $350k | 32k | 10.83 | |
| Health Care SPDR (XLV) | 0.1 | $312k | 49k | 6.39 | |
| V.F. Corporation (VFC) | 0.1 | $316k | 48k | 6.60 | |
| CVS Caremark Corporation (CVS) | 0.1 | $317k | 40k | 7.96 | |
| Yum! Brands (YUM) | 0.1 | $287k | 40k | 7.19 | |
| Schlumberger (SLB) | 0.1 | $293k | 29k | 10.18 | |
| Towers Watson & Co | 0.1 | $279k | 28k | 9.96 | |
| Biolinerx Ltd-spons | 0.1 | $298k | 193k | 1.54 | |
| Astrazeneca Plc-spons Adr call | 0.1 | $306k | 971.00 | 315.14 | |
| Concert Pharmaceuticals I equity | 0.1 | $286k | 23k | 12.60 | |
| Colgate-Palmolive Company (CL) | 0.1 | $262k | 40k | 6.53 | |
| Ellomay Capital (ELLO) | 0.1 | $245k | 191k | 1.28 | |
| Google Inc Class C | 0.1 | $262k | 4.5k | 57.71 | |
| Alcobra | 0.1 | $264k | 561.00 | 470.59 | |
| Brainstorm Cell Therapeutics (BCLI) | 0.1 | $265k | 63k | 4.18 | |
| MasterCard Incorporated (MA) | 0.0 | $192k | 26k | 7.38 | |
| Snap-on Incorporated (SNA) | 0.0 | $195k | 16k | 12.11 | |
| 0.0 | $223k | 3.8k | 58.93 | ||
| TJX Companies (TJX) | 0.0 | $163k | 28k | 5.91 | |
| Auxilium Pharmaceuticals | 0.0 | $30k | 1.0k | 30.00 | |
| Glaxosmithkline | 0.0 | $44k | 2.9k | 15.10 | |
| Ormat Technologies (ORA) | 0.0 | $52k | 20k | 2.61 | |
| Summit Financial | 0.0 | $63k | 25k | 2.52 | |
| Tetraphase Pharmaceuticals | 0.0 | $47k | 2.4k | 19.87 | |
| Macrocure | 0.0 | $51k | 7.1k | 7.18 | |
| Tjx Cos | 0.0 | $22k | 500.00 | 44.00 | |
| Agios Pharmaceuticals (AGIO) | 0.0 | $25k | 405.00 | 61.73 |
